Trailing-twelve-month (TTM) revenue is $898.74 Million with a year-over-year growth of +4.35%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $224,501,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-03 |
| Q4 FY2025Period ended 2025-12-31 | $269,077,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-13 |
| Q1 FY2026Period ended 2026-03-31 | $204,583,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-04 |
| Q2 FY2026Period ended 2026-06-30 | $200,581,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-03 |
| TTM revenue | $898,742,000 |
Current P/S: $2,022,858,939 market capitalization ÷ $898,742,000 TTM revenue = 2.25x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $200.58M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-04T15:48:28.274Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-02.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|
| Operating Segment | $803M | $912M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| All Other Countries | N/A | $12M | $13M | $19M | N/A | N/A |
| Europe | $9M | N/A | N/A |
$898.74M
$898.74 Million
+4.35%
vs. $861.28M a year ago (TTM)
+38.69%
5 Year compound annual growth rate
1 Year
+4.35%
3 Year
+19.54%
5 Year
+38.69%
10 Year
+60.54%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $911.98M | +$109.18M | +13.60% |
| 2024 | $802.80M | +$178.00M | +28.49% |
| 2023 | $624.80M | +$216.94M | +53.19% |
| 2022 | $407.86M | +$174.46M | +74.75% |
| 2021 | $233.39M | +$118.01M | +102.28% |
| 2020 |
TTM Growth
+4.35%
3-Year CAGR
+19.54%
5-Year CAGR
+38.69%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 32 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-04T15:48:28.274Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-02.
| N/A |
| N/A |
| N/A |
| Non-US | N/A | N/A | N/A | N/A | $32M | $40M |
|---|
| UNITED STATES | $106M | $221M | $395M | $606M | $771M | $872M |
|---|
| $115.38M |
| +$33.33M |
| +40.62% |
| 2019 | $82.05M | +$31.46M | +62.18% |
| 2018 | $50.59M | +$22.03M | +77.10% |
| 2017 | $28.57M | +$12.14M | +73.90% |
| 2016 | $16.43M | +$8.41M | +105.03% |
